You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Overview

  • Product nameTreponema pallidum p41 proteinSee all Treponema pallidum p41 proteins and peptides ...
  • Protein descriptionRecombinant fragment. The protein contains the Tr.pallidum p41 immunodominant regions.
  • Expression hostE. coli
  • Properties

  • Purity> 90 % by SDS-PAGE
  • Purification notesInclusion bodies.
  • Biological activityImmunoreactive with sera of Tr.pallidum -infected individuals.
  • FormLiquid
  • Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
  • Storage bufferPreservative: None
    Constituents: 8M Urea, 10mM Tris HCl, 1mM EDTA, 1mM DTT, pH 8
  • Concentration information loading...
  • Research Areas
  • Applications

    Our Abpromise guarantee covers the use of ab43054 in the following tested applications.

    The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

    Application Notes
    WB WB: Use at an assay dependent dilution.
    ELISA ELISA: Use at an assay dependent dilution.

    Protein info

  • RelevanceSyphilis is a chronic, complex sexually transmitted disease of humans caused by the spirochetal bacterium Treponema pallidum. Primary syphilis is characterized by the prevalence of IgG to protein p41 with the total antibody level being low, while early latent syphilis is characterized mainly by prevalence of IgG to protein p17 in the presence of high titers of antibodies.
  • Cellular localizationCell Membrane
  • References for Treponema pallidum p41 protein (ab43054)

    ab43054 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab43054.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"